Home > Insider Trading > Filing (0001181431-10-054757)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341637	Alison Kiley	One Embarcadero Center Suite 3700 San Francisco CA 94111		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-27	315,789	$9.50	2,680,551	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes

Footnotes

This amendment is being filed to correct a typographical error in the amount of securities beneficially owned following all reported transactions and reported in Column 5 of Table I from 2,860,551 shares to 2,680,551 shares.
The Reporting Person is a member of Alta BioPharma Management III, LLC ("ABMIII"), which is the general partner of Alta BioPharma Partners III, L.P. ("ABPIII") and the managing limited partner of Alta BioPharma III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). She may be deemed to share investment power over the securities of the Issuer held by ABPIII, ABPIIIKG and Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII") with the directors of ABMIII and managers of AEBPIII but disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein.
ABPIII acquired 289,236 shares of common stock in the Issuer's public offering, ABPIIIKG acquired 19,425 shares of common stock in the Issuer's public offering and AEBPIII acquired 7,128 shares of common stock in the Issuer's public offering. All shares were purchased at the initial public offering price of $9.50 per share.